Fulcrum Therapeutics
FULC
#6244
Rank
C$1.17 B
Marketcap
C$17.87
Share price
1.48%
Change (1 day)
195.82%
Change (1 year)

EPS for Fulcrum Therapeutics (FULC)

EPS in 2025 (TTM): C-$1.66

According to Fulcrum Therapeutics's latest financial reports the company's current EPS (TTM) is C-$1.62. In 2024 the company made an earnings per share (EPS) of C-$0.28 an increase over its 2023 EPS that were of C-$2.17.

EPS history for Fulcrum Therapeutics from 2019 to 2025

Annual EPS

Year EPS Change
2025 (TTM)C-$1.66503.39%
2024C-$0.28-87.34%
2023C-$2.17-36.29%
2022C-$3.418.3%
2021C-$3.15-18.51%
2020C-$3.87-31.36%
2019C-$5.63

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
ORIC Pharmaceuticals
ORIC
C-$2.38 46.61%๐Ÿ‡บ๐Ÿ‡ธ USA